본문 바로가기
KERD
논문KCI 등재

Clinically Useful Diagnostic Tool of Contrast Enhanced Ultrasonography for Focal Liver Masses: Comparison to Computed Tomography and Magnetic Resonance Imaging

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background/Aims: To evaluate the diagnostic value of contrast(SonoVue®) enhancement ultrasonography (CEUS) andto compare this method with computed tomography (CT) andmagnetic resonance imaging (MRI) in evaluating liver masses. Methods: CEUS (n=50), CT (n=47), and MRI (n=43) wereperformed on 50 liver masses in 48 patients for baselinemass characterization. The most likely impression for eachmodality and the final diagnosis, based on the combinedbiopsy results (n=14), angiography findings (n=36), and clinicalcourse, were determined. The diagnostic value of CEUSwas compared to those of CT and MRI. Results: The final diagnosisof the masses was hepatocellular carcinoma (n=43),hemangioma (n=3), benign adenoma (n=2), eosinophilicabscess (n=1), and liver metastasis (n=1). The overall diagnosticagreement with the final diagnosis was substantial forCEUS, CT, and MRI, with κ values of 0.621, 0.763, and 0.784,respectively. The sensitivity, specificity, and accuracy were83.3%, 87.5%, and 84.0%, respectively, for CEUS; 95.0%,87.5%, and 93.8%, respectively, for CT; and 94.6%, 83.3%,and 93.0%, respectively for MRI. After excluding the lesionswith poor acoustic sonographic windows, the sensitivity,specificity, and accuracy for CEUS were 94.6%, 87.5%, and93.3%, respectively, with a κ value of 0.765. Conclusions: Ifan appropriate acoustic window is available, CEUS is comparableto CT and MRI for the diagnosis of liver masses.

Abstract

Background/Aims: To evaluate the diagnostic value of contrast(SonoVue®) enhancement ultrasonography (CEUS) andto compare this method with computed tomography (CT) andmagnetic resonance imaging (MRI) in evaluating liver masses. Methods: CEUS (n=50), CT (n=47), and MRI (n=43) wereperformed on 50 liver masses in 48 patients for baselinemass characterization. The most likely impression for eachmodality and the final diagnosis, based on the combinedbiopsy results (n=14), angiography findings (n=36), and clinicalcourse, were determined. The diagnostic value of CEUSwas compared to those of CT and MRI. Results: The final diagnosisof the masses was hepatocellular carcinoma (n=43),hemangioma (n=3), benign adenoma (n=2), eosinophilicabscess (n=1), and liver metastasis (n=1). The overall diagnosticagreement with the final diagnosis was substantial forCEUS, CT, and MRI, with κ values of 0.621, 0.763, and 0.784,respectively. The sensitivity, specificity, and accuracy were83.3%, 87.5%, and 84.0%, respectively, for CEUS; 95.0%,87.5%, and 93.8%, respectively, for CT; and 94.6%, 83.3%,and 93.0%, respectively for MRI. After excluding the lesionswith poor acoustic sonographic windows, the sensitivity,specificity, and accuracy for CEUS were 94.6%, 87.5%, and93.3%, respectively, with a κ value of 0.765. Conclusions: Ifan appropriate acoustic window is available, CEUS is comparableto CT and MRI for the diagnosis of liver masses.

참고문헌 (18)

  1. Murakami T, "computed tomography and magnetic resonance imaging of hepatocellular carcinoma : toward improved treatment decisions", Oncology, 81(Suppl 1), pp.86~99 (2011)
  2. Jang JY, "Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions", Clin Mol Hepatol, 19, pp.1~16 (2013)
  3. Trillaud H, "Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI", World J Gastroenterol, 15, pp.3748~3756 (2009)
  4. Schneider M., "Characteristics of SonoVuetrade mark", Echocardiography, 16(7 Pt 2), pp.743~746 (1999)
  5. Nicolau C, "Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions", AJR Am J Roentgenol, 186, pp.158~167 (2006)
  6. Kim TK, "Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound", Abdom Imaging, 36, pp.244~263 (2011)
  7. Bolondi L, "New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice", Dig Liver Dis, 39, pp.187~195 (2007)
  8. von Herbay A, "Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients", J Clin Ultrasound, 38, pp.1~9 (2010)
  9. Seitz K, "Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions: prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos", Ultraschall Med, 30, pp.383~389 (2009)
  10. Strobel D, "Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS)", Ultraschall Med, 30, pp.376~382 (2009)
  11. Wilson SR, "Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI", AJR Am J Roentgenol, 189, pp.W7~W12 (2007)
  12. Piscaglia F, "The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations", Ultrasound Med Biol, 32, pp.1369~1375 (2006)
  13. Sporea I, "How useful is contrast enhanced ultrasonography for the characterization of focal liver lesions?", J Gastrointestin Liver Dis, 19, pp.393~398 (2010)
  14. Sirli R, "Contrast enhanced ultrasound in focal liver lesions: a cost efficiency study", Med Ultrason, 12, pp.280~285 (2010)
  15. Romanini L, "Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience", Eur Radiol, 17(Suppl 6), pp.F99~F106 (2007)
  16. Martie A, "Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma", Med Ultrason, 13, pp.108~113 (2011)
  17. European Association for Study of Liver, "EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma", Eur J Cancer, 48, pp.599~641 (2012)
  18. Bruix J, "Management of hepatocellular carcinoma: an update", Hepatology, 53, pp.1020~1022 (2011)

관련 논문AI추천

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study권상옥, 김문영, 김영주, 박소연, 백순구, 조윤주, 차승환, 최은희대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제2호Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing FactorsBei-Jian Huang, Hao Cai, Hong Ding, Wen-Ping Wang, Wen-Tao Kong, Zheng-Biao Ji거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제2호Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US강태욱, 민지혜, 송경두, 이민우, 임상혁, 임현철, 임효근, 최서연대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제1호Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound이정민, Jeong Hee Yoon, Junghoan Park, Tae-Hyung Kim대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제3호A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions김명진, 박미숙, 서니은, 안찬식, 이진영, 한경화, Gulbahor Rakhmonova대한간학회 · Clinical and Molecular Hepatology2017 · 제23권 제1호Ferucarbotran-Enhanced Hepatic MRI at 3T Unit: Quantitative and Qualitative Comparison of Fast Breathhold Imaging Sequences김기황, 김주희, 유정식, 정재준, 조경은대한자기공명의과학회 · Investigative Magnetic Resonance Imaging2010 · 제14권 제1호

이 간행물의 다른 논문 (15건)